Engineering cellular microenvironments to improve cell-based drug testing

Drug Discovery Today

Volumn 7, Issue 11, 2002, Pages 612-620

  Bhadriraju, Kiran ^a   Chen, Christopher S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BASIC FIBROBLAST GROWTH FACTOR; BETA CASEIN; COLLAGEN; CYCLIN D; CYTOCHROME P450; FIBRIN; INTEGRIN RECEPTOR; MATRIGEL; PHORBOL ESTER; PROLACTIN; PROTEIN P27; VASCULOTROPIN;

BIOTECHNOLOGY; CELL ASSAY; CELL CONTACT; CELL FUNCTION; CELL STRUCTURE; DRUG ACTIVITY; DRUG SCREENING; ENGINEERING; EXTRACELLULAR MATRIX; HUMAN; MICROENVIRONMENT; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; SEMICONDUCTOR; VALIDATION PROCESS; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; DRUG DESIGN; DRUG EFFECT; LIVER CELL; METHODOLOGY; VASCULAR ENDOTHELIUM;

ANIMAL; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; ENDOTHELIUM, VASCULAR; HEPATOCYTES; HUMAN; PHENOTYPE; SEMICONDUCTORS; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; HUMANS;

EID: 0036591838     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(02)02273-0     Document Type: Review

References (69)

1. Recent developments in combinatorial organic synthesis
2. Proteomics: Applications and opportunities in preclinical drug development
3. Drug screening - Beyond the bottleneck
4. Drug discovery and target validation
5. Drug discovery - An operating model for a new era
6. Cell-based screen for antimitotic agents and identification of analogues of rhizoxin, eleutherobin and paclitaxel in natural extracts
7. HTS in the new millennium: The role of pharmacology and flexibility
8. A comparative cell-based high throughput screening strategy for the discovery of selective tyrosine kinase inhibitors with anticancer activity
9. Real-time molecular and cellular analysis: The new frontier of drug discovery
10. Unraveling novel intracellular pathways in cell-based assays
11. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials
12. In vitro models of the intestinal barrier. The report and recommendations of ECVAM Workshop 46. European Centre for the Validation of Alternative Methods
13. In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery
14. Approaches for the development of cell-based in vitro methods for contact sensitization
15. Development and intralaboratory evaluation of an in vitro human cell-based test to aid ocular irritancy assessments
16. In vitro prediction of gastrointestinal absorption and bioavailability: An experts' meeting report
17. Molecules for the millennium: How will they look? New drug discovery year 2000
18. Evolution of anticancer drug discovery and the role of cell-based screening
19. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein
20. Virtual screening of intestinal drug permeability
21. Switching from differentiation to growth in hepatocytes: Control by extracellular matrix
22. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness
23. Geometric control of cell life and death
24. Geometric control of switching between growth, apoptosis and differentiation during angiogenesis using micropatterned substrates
25. The transcriptional program in the response of human fibroblasts to serum
26. Extracellular matrix alters PDGF regulation of fibroblast integrins
27. Extracellular matrix and wound healing
28. Fibroblasts in mechanically stressed collagen lattices assume a 'synthetic' phenotype
29. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: Role of extracellular matrix
30. Insoluble fibronectin activates the Na/H antiporter by clustering and immobilizing integrin α5/β1, independent of cell shape
31. Signal transduction by the platelet integrin alpha IIb beta 3: Induction of calcium oscillations required for protein-tyrosine phosphorylation and ligand-induced spreading of stably transformed cells
32. Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex
33. Cell-cell signaling by direct contact increases cell proliferation via a PI3K-dependent signal
34. Stretching is good for a cell
35. Cell adhesion: The molecular basis of tissue architecture and morphogenesis
36. Engineering cell shape and function
37. Control of cyclin D1, p27 (Kip1), and cell cycle progression in human capillary endothelial cells by cell shape and cytoskeletal tension
38. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution
39. Collagenous substrata regulate the nature and distribution of glycosaminoglycans produced by differentiated cultures of mouse mammary epithelial cells
40. Interaction of mouse mammary epithelial cells with collagen substrata: Regulation of casein gene expression and secretion
41. Extracellular matrix and hormones transcriptionally regulate bovine beta-casein 5¢ sequences in stably transfected mouse mammary cells
42. A hierarchy of ECM-mediated signaling regulates tissue-specific gene expression
43. Angiogenesis: New targets for the development of anticancer chemotherapies
44. The suitability of hepatocyte culture models to study various aspects of drug metabolism
45. Lumen formation during angiogenesis in vitro involves phagocytic activity, formation and secretion of vacuoles, cell death, and capillary tube remodeling by different populations of endothelial cells
46. P38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis
47. Characterization of EG-VEGF signaling in adrenal cortex-derived capillary endothelial cells
48. Enhanced cytochrome P450 IA1 activity of self-assembled rat hepatocyte spheroids
49. Extracorporeal tissue engineered liver-assist devices
50. Regulation of the hepatocyte cell cycle by type I collagen matrix: Role of cyclin D1
51. Hepatocyte function and extracellular matrix geometry: Long-term culture in a sandwich configuration
52. Long-term culture of hepatocytes from human adults
53. Extended primary culture of human hepatocytes in a collagen gel sandwich system
54. Structural polarity and functional bile canaliculi in rat hepatocyte spheroids
55. Probing heterotypic cell interactions: Hepatocyte function in microfabricated co-cultures
56. Controlling cell attachment on contoured surfaces with self-assembled monolayers of alkanethiolates on gold
57. Micropatterned surfaces for control of cell shape, position, and function
58. Microstamp patterns of biomolecules for high-resolution neuronal networks
59. Microcontact printing for precise control of nerve cell growth in culture
60. Engineering gene expression and protein synthesis by modulation of nuclear shape
61. Photopatterning of antibodies on biosensors
62. Formation of microscale gradients of protein using heterobifunctional photolinkers
63. Micropatterning gradients and controlling surface densities of photoactivatable biomolecules on self-assembled monolayers of oligo(ethylene glycol) alkanethiolates
64. Turning on cell migration with electroactive substrates
65. Using electroactive substrates to pattern the attachment of two different cell populations
66. Electroactive monolayer substrates that selectively release adherent cells
67. Microfluidics - Downsizing large-scale biology
68. Patterned deposition of cells and proteins onto surfaces by using three-dimensional microfluidic systems
69. Patterning cells and their environments using multiple laminar fluid flows in capillary networks